Browse Data and Analysis

There has been no change in Bulgarian consumers’ attitude towards biotechnology which remains negative. Non-Governmental Organizations (NGO’s), the Green Party, organic, bee-keeping...

Although public opinion in France is generally opposed to products derived from biotechnology, the livestock industry is dependent upon imported genetically engineered (GE) products to meet...

Saudi Arabia applies Gulf Standardization Organization (GSO) biotech regulations on food and agricultural products. The GSO regulations, issued in 2011, call for biotech labeling if the biotech...

The United Kingdom’s anticipated exit from the European Union (Brexit) will not change policy or trade in genetically engineered plants or animals in the short to medium term.

This report describes production, trade, research, policy, and marketing issues of genetically engineered (GE) plant and animal products in Italy.

Although public opinion in France is generally opposed to products derived from biotechnology, the livestock industry is dependent upon imported genetically engineered (GE) products to meet its needs.

Taste of America 2016, Kuze Tradeshow, Seafood Show, American Fruits and Sweets Fair, American & Hawaiian Fair in Osaka, USMEF Heartland Team, Okinawan Cow-Calf Research, Nippon Ham Fighters...

This report assesses the agricultural biotechnology sector in the Netherlands, and covers related production, trade and policies. It includes topics related to genetic engineering and innovative...

The biotechnology regulatory system in Ukraine is still not fully developed, but the country has committed itself towards shaping its policy in-line with European Union standards.

There have not been any significant developments to report since last year’s 2015 report...

As of July 2016, Israel does not have a policy that restricts the use of imported genetically engineered (GE) commodities or derivative products.

Again, this year, Italy’s biotechnology industry is characterized as a dynamic and promising sector, despite the difficult economic situation that biotech companies have to confront on a daily basis